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Abstract
Background: Micronutrient deficiencies occur early in Human Immunodeficiency Virus (HIV) infections they have
reverse effects on the nutritional status. The diet supplementation with a natural nutraceutical rich in proteins and
micronutrient like Spirulina platensis, may be effective and efficient in delaying HIV disease progression by frequently
reported improvement in immune response.
Methods: A prospective single-blind, randomized, multicenter study conducted on 320 HIV-1 ARV-naïve participants
for 12 months. Participants received either S. platensis supplementation and standard care or standard care and local
balanced diet without S. platenis. Selected hematological and biochemical as well as CD4 count cells, viral load copies
were assessed at three separate times.
Results: Among the 169 ART-naïve participants enrolled in the study, the female was mostly represented (67.1 %). The
significant increase of CD4 count cells (596.32–614.92 cells count) and significant decrease of viral load levels
(74.7 × 103–30.87 × 103 copies/mL) of the patients who received a supplementation of S. platensis was found
after 6 months of treatment. Haemoglobin level was also significantly higher in the same group while the fasting
blood glucose concentration decreased after 12 months compared to control.
Conclusion: A daily supplementation with S. platensis to diet combined with a reasonable balanced diet has
significantly increased the CD4 cells and reduced the viral load after 6 months. Further studies are recommended
among a large specific group of people infected by the HIV in order to investigate the mechanisms involved on the
effect of S. platensis on immune system.
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Introduction
One of the several Public Health problems faced in
Sub-Saharan Africa is HIV/AIDS. In Cameroon, about
4.3 % of the population are infected and this prevalence
is particularly higher among women and individuals
aged between 15 and 49 years [1, 2]. In Africa in general
and Cameroon in particular, HIV/AIDS pandemic has
created a new form of vulnerability with regards to food
security and nutrition. Poverty and food insecurity
impacts feeding habits and the reduce access to a nutri-
tion rich in macro and micronutrients which lead to the
health impairment mainly in HIV patients [3].
Malnutrition potentialises the effects of HIV infection
on the individual by promoting chronic fatigue and
disease progression, the latter lead to the morbidity and
earlier death [4]. Malnutrition is an important factor that
affects the care of patients infected by the HIV, their
treatment and it contributes to the development of
opportunistic infections such as tuberculosis [5, 6].
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Malnutrition and HIV also have similar deleterious
effects on the immune system and in both cases there
are reduced CD4 and CD8 T-lymphocyte levels and
impaired serological response after immunizations [7].
The synergistic effects of malnutrition and HIV on the
immune system occur in a vicious cycle in which the
decrease of immunity associated with higher risk of
development of other infectious diseases. HIV-infected
adults and children are encouraged to consume healthy
diets and individuals with HIV/AIDS require greater
protein and micronutrient intake to support a weakened
immune system [8]. International organizations have
called for food assistance to be integrated into HIV
treatment and prevention programs, but evidence-based
guidance on how exactly to implement such programs,
on what beneficiaries to target, and on what the optimal
components or duration of food assistance should be
not yet well described [9]. Therefore, dietary supple-
ments are often used by people living with HIV infection
to ‘boost immune functioning’ such as mega-dose vita-
mins, anti-oxidants and body cleansing products such as
teas and herbs to remove ‘toxins’ [10].
To fight against nutrients deficiency mainly to HIV
patients, the World Health Organization (WHO) recom-
mends nutrients intake of each required micronutrients,
which may be taken through nutrient supplementation
[6, 11]. Due to the difficulties to access to a balanced
diet, Spirulina platensis a cyanobacterium available in
sub-Saharan Africa has been used as food source. S. pla-
tensis represents an important staple diet in humans and
has been used as a source of protein and vitamin supple-
ment in humans without any significant side-effects [12].
It contains protein (up to 70 %), vitamins, especially B12
and provitamin A (β-carotenes), and minerals, especially
iron and other bioactives moleucles such as phenolic
acids, tocopherols and glinolenic acid [2, 12]. Several
studies demonstrated beneficial effects of S. platensis in
vitro and in vivo as well as its therapeutic functions [13,
14]. In addition, some studies show that spirulina has
beneficial effects on the treatment of malnutrition and
on other pathologies such as obesity, hypercholesterol-
aemia, arterial hypertension and diabetes mellitus [15–17].
This study was performed, to assess the potential effects of
10 grams of daily supplementation of S. platensis with a
local balance diet on the level of CD4 cells count and viral
load during six months by treatment naïve HIV–infected
persons.
Methods
Selection of population of study
We carried out a longitudinal study in a randomized co-
hort from January 2011 to February 2012. Patients aged
between 18–65 years, HIV–infected naïve to antiretro-
viral treatment and with CD4 count ≥400 cells/μL were
eligible. Patients who had their CD4 below 400 cells/μL
during the follow-up were excluded. Informed consent
was obtained from every subject prior to the participa-
tion for the study. The study was approved by the
Cameroon National Ethic Committee under the follow-
ing reference number: 123/CNE/SE/2011, Cameroon.
The subjects were recruited through the medical file
obtained from the Day Care Clinic of Central Hospital
of Yaounde (CHY) and of the Biyem-Assi District
Hospital. Investigation and intervention were carried out
at the Etoug-Ebe Health Center.
Selection, randomization, treatment allocation and
follow up
Selected participants (169 subjects) were included in the
study. They were divided into two groups: 87 subjects to
the control group (first group) and 82 subjects to the
intervention group (second group). HIV infected pa-
tients were selected after checking patients files for CD4
counts over 400 cells/μL who were ARV naïve to
treatment (Fig. 1). The two groups were matched with
respect to age, sex, and CD4 cells counts. At the inclu-
sion in the study, patients had been fasting for at least
eight hours overnight. The patients of the first group
were advised who to take a local balance diet while
patients of the second group were asked to add 10 g of
S. platensis to their usual diet during the first six
months. The S. platensis was given in package of powder
doses of 10 grams per day. The next six months were
for the follow-up without S. platensis powder. Subjects
were treated “as usual care” treatment in Cameroon. To
monitor the biological parameters a standardized
questionnaire for demographic characteristics, clinical,
quality of live was filled by the subjects at the baseline,
during and at the end of the trial.
Determination of biochemical parameters
The biochemical indexes were monitored three times: at
the baseline, after six and twelve months where the
blood samples were collected in three tubes of 4 mL.
The first tube was used to determine the CD4 lympho-
cytes count by all patients. A volume of 50 μL of periph-
eral blood collected was labeled for Flow Cytometry
using BD CD4 multitest kits according to Manufacturer’s
instructions. Samples were the acquired using BD FACS
CALIBUR II Machine (BD Biosciences, Germany). CD4 T
cells values were expressed as cells/μL. The second tube
was used for the determination of the viral load with an
Abbott Real time PCR (Abbot, USA). HIV-1 Amplification
Strategy with a detection limit of 40 copies/mL. The
hemoglobin and the fasting blood sugar levels were
determined in the third tube using a standard method
and the « ULTRA ONE TOUCH” glucometer (LifeScan,
Inc.,USA) respectively. The level of glycemia higher
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than ≥ 110 mg/dL was identified like cardiovascular
risk factors.
Statistical analysis
Data were presented as mean ± standard deviations or
when indicated as percentage. Chi-square was performed
to determine the significance of differences in the preva-
lence of opportunistic infections in both groups.
Student’s t-test version 3.3.2 was used to compare
the CD4 lymphocytes counts and viral load of both
groups. The statistical SPSS program (version 16.0)
was used for all the analysis. Results were considered
significant at p-value less than 0.05.
Results
A total of 169 patients were enrolled on the study among
them 50 men and 119 female (Fig. 1). The women were
more represented with a sex ratio of 2.38. After 6 months
27 patients (17.53 %) were dropped from the study these
included 4 subjects (2.59 %) from the control group and
23 subjects (14.93 %) from spirulina group. These patients
were dropped out because there were HIV–negative due
to the error of screening test (6.89 % (6/87) in the control
group and 3.65 % (3/82) in the spirulina group) or due to
the reduction of CD4 cells count lower than 350 cells/mL
(2.29 % (2/87) in the control group and 19.5 % (17/82) in
the spirulina group) (Fig. 1).
Clinical characteristics of the 169 HIV–infected anti-
retroviral naïve patients are presented in (Table 1). The
results clinical characteristics of patients in the Spirulina
group and control showed at the beginning of the study,
the presence of sexual transmitted infections (3 %, 16 %),
malaria (6 %, 13 %) and Zona (3 %, 7 %). After 12 months
most of these clinical manifestations significantly reduced
in the group of patient who added spirulina to their diet.
As for lifestyle, the percentage of patients who practiced
physical activity (50 %, 60 %), drank alcohol and smoke to-
bacco respectively (3; 20 %) (1 %; 4 %) did not change.
The results presented the demography of the popula-
tion of study showed that there were more women
(76.1 %) than men (23.9 %) in the study with a sex ration
of 2.38 (Table 2). The two groups (control and spirulina)
were similar with respect to age, sex. The mean age was
35.6 ± 9 years. The value of the BMI was no significantly
differences during the twelve months in both groups.
The fasting blood sugar was decreased significantly after
12 months in the group of patients who added 10 g of S.
platensis in their diet compare to the control group. No
significant difference was observed in fasting blood sugar
in both groups at the first 6 six months. The level of Hb
was significantly higher in the spirulina group after
6 months compared to the control group. These results
demonstrated that S. platensis could ameliorate the fast-
ing blood sugar and the hemoglobin of the HIV-naïve
patients.
Effects of S. platensis on the CD4 lymphocytes T and
viral load
To investigate the effects of S. platensis on the immune
response of the HIV-naives patients, the CD4 cells count
Fig. 1 Flow chart describing progress of participants through the Spirulina platensis supplementation trial
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Table 2 Demographic and clinical characteristics of patients during the trial
Variables Ctrl/Spi Period Patients received local balance diet Patients received spirulina combined
with a local balance diet
p-value
Age (Years) 87/82 T0 35.43 ± 10.04 36.01 ± 9.44 0.58
Sex (%)
Female 87/82 T0 64.5 % (56) 69.8 % (60) 0.06
Male 35.6 % (31) 25.6 % (22)
BMI (kg/m2) 87/82 T0 26.02 ± 4.97 25.29 ± 4.54 0 .33
79/80 T6 25.18 ± 6.41 25.41 ± 4.98 0.80
66 /79 T12 22.18 ± 1.07 23.26 ± 6.53 0.44
CD4 (cells/μL) 87/82 T0 569.40 ± 179.89 596.32 ± 198 0.36
79/80 T6 464.86 ± 200.33 609.07 ± 149.14 <0.00*
66/79 T12 429.04 ± 177.19 614.92 ± 179.43 <0.00*
Viral load (copies/mL) 87/82 T0 61199.03 ± 6.27 74770.33 ± 3.19 0.53
79/80 T6 66615,45 ± 7.45 38539.70 ± 2.22 <0.00
66/79 T12 174595.22 ± 1.20 30872.33 ± 3.93 <0.00
Hemoglobin (mg/dL) 87/82 T0 12.87 ± 1.53 13.14 ± 1.85 0.32
79/80 T6 12.22 ± 1.42 13.49 ± 1.24 <0.00
66/79 T12 11.69 ± 1.62 12.71 ± 1.71 <0.00
Fasting Blood Sugar (mg/L) 87/82 T0 115 ± 53.70 105.89 ± 25.91 0.159
79/80 T6 105.00 ± 30.76 103.14 ± 15.93 0.65
66 /79 T12 113.77 ± 61.85 95.35 ± 9.63 <0.00*
Mean values ± SD. *Significant difference between the group (P < 0.00). Significant difference between the group (p < 0.05). Ctrl: Control, Spi: Spirulina group;
To, T6,T13: time (months)
Table 1 Clinical characteristics parameters of patients of the study
Parameters T0 T6 T12
Spi (%) Ctrl (%) Spi (%) Ctrl (%) Spi (%) Ctrl (%)
Malaria 8 9.1 2 2.29 5 4.74 21 62.5 03 37.5 18 20.68
Stomach ache 12 13.7 18 20.68 7 8.04 18 20.68 5 5.74 13 14.94
Chronic fatigue 24 27.4 11 12.64 4 4.56 8 9.2 2 2.29 12 13.1
Lack of appetite 11 12.64 17 19.54 8 9.1 6 6.89 1 1.14 8 9.2
More of appetite 0 0 0 0 22 25.28 14 16.09 23 26.43 9 10.34
Diarrhoea 0 0 0 0 0 0 8 9.1 0 0 0 0
Vomits 0 0 1 0 1 1.14 4 4.56 1 1.14 1 1.14
Vaginal itches 4 4.59 5 4.74 3 3.44 2 2.29 3 3.44 3 3.44
Candidiasis 5 5.74 4 4.56 0 0 4 4.56 0 0 3 3.44
Cough 0 0 0 0 2 2.29 6 6.89 1 1.14 8 9.1
Pinples on the skind 2 2.29 2 2.29 3 3.44 1 1.14 3 3.44 3 3.44
Others sikness 2 2.29 4 4.67 3 3.44 3 3.44 3 3.44 3 3.44
Alcohol 4 4.56 6 6.89 3 3.44 4 4.56 3 3.44 4 4.56
Smoking 2 2.29 3 3.44 2 2.29 3 3.44 1 1.14 2 2.29
Ctrl Control, Spi Spirulina group; T0, T6, T12: time (months)
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and the viral load of the patients were determined. The
results of the CD4 cells count showed that at the base-
line of the study there was no significant variation be-
tween patients of control and spirulina group. After
6 months of intake of spirulina powder these values
linearly (R2 = 0.95) and significantly increased until
12 months in the spirulina group while in the control
group a linear reduction (R2 = 0.96) of CD4 cells was noted
(Fig. 2). In contrary, the viral load of the spirulina group
significantly reduced while that of the control group in-
crease significantly during the experiment (Fig. 3). These
results showed that spirulina supplementation intake posi-
tively and significantly stimulated the immune system and
inhibit the replication of viral on HIV-l naïve patients.
Discussion
This present randomized control study included 169 pa-
tients divided into two groups either 87 (control group)
Fig. 2 Variation of CD4 cells count during the period of experiment. Values are expressed as mean values ± SD, Ctrl: Control, Spi: Spirulina group;
n = 78 after 6 months and n = 68 after 12 months; p < 0.01
Fig. 3 Variation of viral load of the groups during the experiment. Values are expressed as mean values ± SD, Ctrl: Control, Spi: Spirulina group;
n = 78 after 6 months and n = 68 after 12 months; p < 0.01
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or 82 (spirulina group). Our sample size and the dur-
ation of the experiment were respectively higher and
longer than previous study conducted in Cameroon
which had 73 and 53 patients for 12 weeks [14, 18]. The
choice of a balance local diet for the control group was
due to the fact that, the resources setting were limited
and this approach could reduce nutritional deficiency
and improve the status of the HIV treatment naïve pa-
tients. In addition, adequate nutritional status supports
immunity and physical performance [6, 11]. This result
also corroborates studies which report that adequate
nutrition promotes and maintains optimal immune func-
tion [19]. We demonstrated in this study that supple-
mentation with S. platensis during 06 months and after
06 months of follow up resulted in an increase CD4
count and hemoglobin level, a decrease of viral load.
The improvement of the well-being of the patients
through the regression of opportunistic diseases was also
found in this group compared to the control group. This
result confirms that individuals receiving S. platensis
were significantly more likely to schedule clinic visits
than those not receiving food assistance [9]. Several
investigators have shown that adequate nutrition associ-
ated with or without education and counseling can
improve nutritional status both during stable treatment
free period and during severe episodes of the infection
[20]. Our results showed that more than 50 % of patients
from spirulina group found the significant regressions of
opportunistic disease. This result is due to the presence
of a large amount of macro and micronutrient identified
in S. plantensis which can improve the immune system
or prevent these opportunistic diseases [2, 21]. Several
studies confirmed the beneficial effects of S. platenis
supplements, vitamins or minerals on the immune
system of VIH patients [14, 22]. Our results showed that,
after 06 months of S. platensis supplementation intake,
the patients of the intervention group continued to show
a significant decrease of the viral load and an increase of
the CD4 count compared to the control group (Fig. 3).
Feeding studies showed that even in small amounts it
can build up both humoral, cellular arms of the immune
system and also enhances the body’s ability to generate
new blood cells [12, 23]. Extract of S. platensis has been
reported to possess in vitro antiviral and anti-AIDS ac-
tivities [12, 24]. Also several in vitro and in vivo antiviral
mechanisms of S. platensis extract have suggested that
(i) the S. platensis extract acts by avoiding the virus to
attach and penetrate to the cell membrane to infect the
cell [24]. Therefore, the stuck virus cannot replicate and
should be eliminate by natural defense of the body; (ii)
the calcium-spirulant (Ca-SP) and sodium spirulant
(Na-SP) found in the S. platensis extract interfered with
replication of viruses including HIV-1, they increase
the activation of macrophages, T-and NK cell activities
[12, 25, 26]; (iii) Polysaccharides, phycocyanin, glyco-
lipids and sulfolipids idenfied the S. platensis extract
increase the immunity by enhancing bone marrow
reproduction, growth of thymus and spleen and bio-
synthesis of serum protein; (iv) the presence of phenolic
acids, tocopherols and ß-carotene and other antioxidant
molecules identified in S. platensis exhibited the antioxi-
dant protection with many benefits both in vitro and in
vivo. Since the baseline characteristics between the two
groups were similar, the beneficial effects noted in the
Spirulina group demonstrated that nutritional supple-
mentation for 6 months led to an improved recovery of
the immune system and an improvement in the body’s
ability to fight infections.
Conclusion
This clinical trial demonstrated that six months supple-
mentation of S. platensis and six months of follow up of
HIV-infected, ART-naïve patients in the early stages of
disease significantly delayed time to HIV disease pro-
gression and reduced the opportunistic diseases. Daily
consumption of S. platensis coupled with nutritional
counseling significantly was found to be strongly associ-
ated to the significantly reduction of the viral load and
increase the CD4 cells counts but the mechanism by
which S. platensis may induce these beneficial effects is
not well understood. Other studies need to be conducted
on the HIV-naive patients to elucidate this mechanism.
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